Form 4: Fractyl Health Director William Bradley Granted Future Stock Options as Compensation

Fractyl Health, Inc. Director William Bradley was granted 22,500 stock options with an exercise price of $2.27, with the grant effective date scheduled for June 11, 2025, as part of his non-employee director compensation.

Summary

• William Bradley, a Director of Fractyl Health, Inc. (GUTS), was granted 22,500 stock options.
• The transaction date for this grant, which is also the grant date, is June 11, 2025.
• The exercise price for these options is $2.27 per share.
• The options were awarded as compensation for his service on the Issuer's board of directors, in accordance with the company's non-employee director compensation policy.
• The stock options will vest and become exercisable in a single installment on the earlier of the date of the next annual meeting of stockholders or the first anniversary of the grant date, subject to continued service on the board.
• The expiration date for these options is June 10, 2035.

Sentiment

Score: 5

Explanation: The document reports a standard compensation event for a director, which is a neutral operational activity and does not inherently indicate positive or negative company performance or outlook.

Positives

• The grant of stock options aligns the director's interests with those of shareholders, as the options gain value if the company's stock price increases.
• The compensation policy for non-employee directors is in place, indicating structured governance regarding board remuneration.

Future Outlook

The granted stock options are scheduled to vest and become exercisable in a single installment on the earlier of the date of the next annual meeting of stockholders or the first anniversary of the grant date (June 11, 2025), contingent upon William Bradley's continued service as a non-employee director. The options have an expiration date of June 10, 2035.

Industry Context

This filing represents a routine compensation event for a director in the biotechnology or healthcare industry, where equity grants are a common component of executive and board remuneration to align interests with long-term company performance.

Related Party Transactions

• The grant of stock options to William Bradley, a director, constitutes a related party transaction as it involves compensation from the company to an insider.

Stakeholder Impact

• Shareholders: The grant of options dilutes existing shareholder equity slightly upon exercise but aims to align the director's interests with long-term shareholder value creation.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The stock options are expected to vest on the earlier of the next annual meeting of stockholders or June 11, 2026 (first anniversary of the grant).

Key Dates

Keywords

Fractyl Health, GUTS, Stock Option, Director Compensation, SEC Form 4, Insider Transaction, Equity Grant, William Bradley